DIRS.INFO The most relevant business & tech news

Even as the market rallies, the latest short interest data reveals several stocks that could see losses. CNBC Pro screened FactSet data for stocks trading on the New York Stock Exchange and Nasdaq Exchange with the most short interest as of Jan. 12. Lucid Group , another EV maker, saw short interest increase to about 29% of its float. Companies that make auto parts, including Luminar Technologies and Atmus Filtration , also saw short interest increase. Short interest increased 3% and 8% for thrift store chain Savers Value Village and department store Kohl's , respectively.

Persons: Fisker, That's, VinFast, Goldman Sachs, Nick Wells Organizations: Nasdaq, CNBC, New York Stock Exchange, Nasdaq Exchange, Lucid Group, Traders, EV, VinFast, Companies, Luminar Technologies, Dyne Therapeutics, Enliven, Allogene Therapeutics

Investors upped their short bets on a handful of clean energy and biotechnology stocks during the first half of July, according to FactSet data. Allogene Therapeutics held the greatest short interest of the group, at about 54% of float, with Novavax and ProKidney Corp. also appearing on the list. Short interest declined slightly in ProKidney shares. Short interest in shares declined 8.6% during the first half of July, although about 35% of its shares are sold short. saw short interest leap 10% since the end of June.

Persons: BioXcel Organizations: BioXcel Therapeutics, Allogene Therapeutics, ProKidney Corp, Research, CNBC Pro, New York Stock Exchange, Nasdaq

☆ The market is going through a short squeeze of historic proportions, even bigger than the meme craze
▼ + stars: | 2023-07-24 | by ( Yun Li | ) www.cnbc.com time to read: +2 min

Remember the GameStop mania of 2021, fueled as it was by forcing short sellers to cover their bets? However, when the stock jumps instead, it forces short sellers to buy back shares in order to limit their losses. The stock market is in the middle of a strong rally as inflation pressures ease and the Fed nears the end of its rate-hiking campaign. GameStop was once the most shorted stock in the market, with short interest as a percentage of shares available for trading exceeding 100%. Carvana , Novavax, Lucid Group and Beyond Meat were also heavily targeted by short sellers.

Persons: Adam Parker, Trivariate, Parker Organizations: Research, Fed, Dow Jones, GameStop, Nasdaq, Therapeutics

As of March 15, short interest against Tattooed Chef rose nearly 4% to 17.1 million shares, which is about 35% of the total float, according to FactSet data. The percentage of float refers to the number of shares that are sold short divided by the the total number of shares available for trading. Short interest in another plant-based food company, Beyond Meat, remained elevated even after falling slightly by 2.5% to around 21 million shares. Other companies that saw a surge in short interest this month include a number of biotech companies. In the first half of March, investors increased their bets against Allogene Therapeutics by about 8% to 39.8 million shares, or about half its total float.

☆ JPMorgan says this biotech stock could rally 60%
▼ + stars: | 2023-01-24 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

JPMorgan has moved off the sidelines on Allogene Therapeutics , a clinical-stage immuno-oncology company the bank believes could see positive catalysts. Analyst Brian Cheng upgraded the stock to overweight from neutral. Cheng also cut his price target nearly in half to $11 from $20, but the new forecast implies the stock will gain 60.3% over the next year. The CD19 franchise is centered around studies for relapsed or refractory non-Hodgkin lymphoma. The analyst noted that one concern about the company is the state of its BCMA franchise, which is focused on treatments for relapsed and refractory multiple myeloma.

Investors seem to be mounting bets against some biotech and pharma names, including one that has soared in 2022. Short interest in Verve rose to 12 million shares, or 34% of its float, while 27.6 million shares of Allogene were being shorted through the end of September. Retailers Bed Bath & Beyond and Big Lots, along women's fashion company Torrid Holdings, also saw increased short interest. Short interest data is updated twice a month and reported mid-month and at the end of the month. The next release date is Oct. 25 for short interest data as of Oct. 14).

☆ SCOOP: Sen. Dianne Feinstein fails to disclose husband's stock purchase, says she's willing to pay a fine
▼ + stars: | 2021-01-27 | by ( Dave Levinthal | ) www.businessinsider.com time to read: +5 min

Sen. Dianne Feinstein's husband, investment banker Richard Blum, invested up to $50,000 in polling firm The Generation Lab. But the Democratic lawmaker didn't disclose the purchase until this month, weeks after a federal deadline. Feinstein has not yet been contacted by the Senate Ethics Committee on whether she will face a fine, Mentzer added. Members of Congress are generally allowed to buy and sell individual stocks — to the chagrin of some government reform advocates — so long as they publicly disclose the transactions. Not until May did Feinstein publicly disclose her husband's Facebook stock purchase, investigative journalism outfit Sludge revealed later in 2018.

Search resuls for: "Allogene Therapeutics"

7 mentions found